Sonoma Pharmaceuticals, Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
This is a routine quarterly (10-Q) filing for Sonoma Pharmaceuticals for the period ending June 30, 2026, filed August 6, 2026. The filing contains standard certification documents and XBRL data files but no substantive business, financial, or transactional details are visible in the provided metadata. No specific dollar amounts, counterparties, deals, or operational changes are disclosed in the text provided.
Why this rating
Routine periodic SEC disclosure; no material business event disclosed in filing metadata provided. Standard quarterly compliance filing.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.